Abstract
134P Doxorubicin and olaparib (OLA) synergism in high-grade serous ovarian (HGOC) and triple-negative breast cancer (TNBC) cell lines with olaparib-resistance
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have